Results 41 to 50 of about 23,997 (201)
Complexities of care in a pediatric patient with epidermolysis bullosa acquisita and duchenne muscular dystrophy: a case report [PDF]
Journal of Medical Case ReportsBackground Type VII collagen autoantibodies drive epidermolysis bullosa acquisita (EBA), a rare autoimmune blistering disorder. While typically seen in adults, pediatric cases—especially those with additional comorbidities—present unique clinical ...
Khayry Al-Shami +7 more
doaj +2 more sources
Epidermolysis bullosa acquisita as an adverse effect from rituximab therapy: A case report. [PDF]
Medicine (Baltimore), 2020 Rationale: Rituximab is a monoclonal antibody directed against B cells and is a first-line agent for the treatment of B cell lymphoma and a second-line agent for the treatment of idiopathic thrombocytopenic purpura (ITP).
Wu X, Lv Z, Li W, Meng Z, Wan SP.
europepmc +2 more sources
Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita. [PDF]
Front Immunol, 2019 Epidermolysis bullosa acquisita (EBA) is an autoimmune skin blistering disease characterized by IgG autoantibodies (aAb) against type VII collagen (COL7).
Kovacs B +8 more
europepmc +2 more sources
Epidermolysis bullosa acquisita: current diagnosis and therapy [PDF]
Dermatology Reports, 2011 Epidermolysis bullosa acquisita (EBA) is an acquired, autoimmune subepidermal blistering disease with an approximate prevalence of 0,2/million people. The hallmark of EBA is the presence of autoantibodies (mainly IgG class) to anchoring fibril collagen ...
Christine R. Mehren, Robert Gniadecki
doaj +2 more sources
Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients. [PDF]
Orphanet J Rare Dis, 2018 BackgroundEpidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Several clinical phenotypes have been described, but subepidermal blistering is characteristic of all variants.
Iwata H +8 more
europepmc +2 more sources
Porphyria Cutanea Tarda Masquerading as Epidermolysis Bullosa Acquisita: A Report of Two Cases
Case Reports in Dermatology, 2015 Porphyria cutanea tarda (PCT) is the most common type of porphyria worldwide and is often initially diagnosed when cutaneous manifestations arise.
Kristyn Deen, Jason Wu
doaj +2 more sources
Epidermolysis Bullosa Acquisita
Indian Journal of Dermatology, 1997 A 35 years old man presented with features of epidermolysis bullosa acquisita. Here is the case report.
Gangopadhyay Asok Kumar
doaj +3 more sources
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
Acta Dermato-Venereologica, 2021 In pemphigoid diseases, direct immunofluorescence can be used to differentiate 2 patterns of antibody deposition at the dermal–epidermal junction; u- and n-serrated pattern.
Maike M. Holtsche +5 more
doaj +1 more source
Journal of Investigative Dermatology, 2023 Autoantibodies against the dermal-epidermal junction component type VII collagen (C7) trigger skin disease in the inflammatory form of epidermolysis bullosa acquisita. We have previously identified the Syk tyrosine kinase as a crucial participant of anti-
T. Németh +4 more
semanticscholar +1 more source